High expression B3GAT3 is related with poor prognosis of liver cancer
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 14 (1) , 251-258
Abstract
Liver cancer is one of the most malignant tumors with poor prognosis. Finding molecular markers that can predict prognosis is very important for the treatment of liver cancer. The present research is trying to find a new biomarker for human liver cancer. The analysis of abnormal expression genes and prognosis value on liver cancer by Gene Expression Profiling Interactive Analysis (GEPIA) database, the Pathology Atlas of the Human Protein Atlas (HPA), and Kaplan Meier-plotter (KM plotter), proved that B3GAT3 might be one of the important candidates. Furthermore, we investigated the specific role of B3GAT3 on liver cancer through the transfection of B3GAT3 siRNA in HepG2 cells. The proliferation was detected using CCK8, and migration and invasion were determined using Transwell assay. Our results proved that knockdown of B3GAT3 inhibited the proliferation, migration, and invasion. Moreover, B3GAT3 knockdown inhibited the expression of EMT related proteins, N-cad, Snail, and Twist, while promoting the expression of E-cad, suggesting that B3GAT3 knockdown reversed the EMT process of liver cancer cells. In conclusion, overexpressed B3GAT3 promotes the process of tumor EMT, which is an independent prognostic marker to predict the prognosis of liver cancer and might be a potential new target for liver cancer therapy.Keywords
This publication has 24 references indexed in Scilit:
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patientsBreast Cancer Research and Treatment, 2016
- Agkihpin, a novel SVAE may inhibit the migration and invasion of liver cancer cells associated with the inversion of EMT induced by Wnt/β-catenin signaling inhibitionBiochemical and Biophysical Research Communications, 2016
- Physical and Chemical Gradients in the Tumor Microenvironment Regulate Tumor Cell Invasion, Migration, and MetastasisCold Spring Harbor Symposia on Quantitative Biology, 2016
- Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β–SMAD3 pathway in non-small cell lung adenocarcinomaProceedings of the National Academy of Sciences, 2014
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Proteoglycans in cancer biology, tumour microenvironment and angiogenesisJournal of Cellular and Molecular Medicine, 2011
- ECM Molecules Mediate Both Schwann Cell Proliferation and Activation to Enhance Neurite OutgrowthTissue Engineering, 2007
- Evidence of calcium‐dependent pathway in the regulation of human β1,3‐glucuronosyltransferase‐1 (GlcAT‐I) gene expression: a key enzyme in proteoglycan synthesisThe FASEB Journal, 2006
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Versican: a versatile extracellular matrix proteoglycan in cell biologyCurrent Opinion in Cell Biology, 2002